Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway.

[1]  K. Yeh,et al.  Acacetin from Traditionally Used Saussurea involucrata Kar. et Kir. Suppressed Adipogenesis in 3T3-L1 Adipocytes and Attenuated Lipid Accumulation in Obese Mice , 2017, Front. Pharmacol..

[2]  N. Habib,et al.  Non-alcoholic fatty liver disease: A sign of systemic disease. , 2017, Metabolism: clinical and experimental.

[3]  Xuchen Zhang,et al.  Non-alcoholic fatty liver disease: An expanded review , 2017, World journal of hepatology.

[4]  J. Quiles,et al.  Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation , 2017, Nutrients.

[5]  P. Hwang,et al.  Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes , 2017, Marine drugs.

[6]  Chian-Jiun Liou,et al.  Phloretin Attenuates Allergic Airway Inflammation and Oxidative Stress in Asthmatic Mice , 2017, Front. Immunol..

[7]  Min-Jung Seo,et al.  Fucoxanthin Suppresses Lipid Accumulation and ROS Production During Differentiation in 3T3‐L1 Adipocytes , 2016, Phytotherapy research : PTR.

[8]  G. Steinberg,et al.  Treatment of nonalcoholic fatty liver disease: role of AMPK. , 2016, American journal of physiology. Endocrinology and metabolism.

[9]  J. Tomlinson,et al.  Non-alcoholic fatty liver disease and diabetes , 2016, Metabolism: clinical and experimental.

[10]  J. Goldstein,et al.  Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex , 2016, Proceedings of the National Academy of Sciences.

[11]  T. Maoka,et al.  Anti-Oxidative Activity of Mytiloxanthin, a Metabolite of Fucoxanthin in Shellfish and Tunicates , 2016, Marine drugs.

[12]  R. Wanders,et al.  The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders. , 2016, Annual review of physiology.

[13]  Antonia A. Dominguez,et al.  Transcriptional regulation of hepatic lipogenesis , 2015, Nature Reviews Molecular Cell Biology.

[14]  F. Villarroya,et al.  Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. , 2015, American journal of physiology. Endocrinology and metabolism.

[15]  G. Frühbeck,et al.  Regulation of adipocyte lipolysis , 2014, Nutrition Research Reviews.

[16]  Hui-Pei Huang,et al.  The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase. , 2014, Journal of the science of food and agriculture.

[17]  Meng Wei,et al.  Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. , 2013, Oncology reports.

[18]  Wei-Tien Chang,et al.  Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3-L1 cells and in macrophage-adipocyte co-cultures. , 2013, Molecular nutrition & food research.

[19]  G. Hassanzadeh,et al.  Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  Yun-Ching Chang,et al.  Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. , 2013, Journal of agricultural and food chemistry.

[21]  S. Surapureddi,et al.  Hepatic steatosis and peroxisomal fatty acid beta-oxidation. , 2012, Current drug metabolism.

[22]  Yu‐Ting Chiu,et al.  Fucoxanthin enhances HO-1 and NQO1 expression in murine hepatic BNL CL.2 cells through activation of the Nrf2/ARE system partially by its pro-oxidant activity. , 2011, Journal of agricultural and food chemistry.

[23]  M. Korbonits,et al.  AMPK as a mediator of hormonal signalling. , 2010, Journal of molecular endocrinology.

[24]  Lulu Chen,et al.  Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase , 2008, Acta Pharmacologica Sinica.

[25]  H. Sul,et al.  Direct Interaction between USF and SREBP-1c Mediates Synergistic Activation of the Fatty-acid Synthase Promoter* , 2007, Journal of Biological Chemistry.

[26]  Nicole A. Ducharme,et al.  Minireview : Lipid Droplets in Lipogenesis and Lipolysis , 2008 .